Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyobo Co Ltd
Original Assignee
Toyobo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyobo Co LtdfiledCriticalToyobo Co Ltd
Priority to JP62209946ApriorityCriticalpatent/JPS6452792A/en
Publication of JPS6452792ApublicationCriticalpatent/JPS6452792A/en
PURPOSE:To obtain the titled factor useful for hematopiesis after chemotherapy, radiotherapy or transplanting of bone marrow for cancer, by keeping human urine under alkaline condition and treating the human urine with molecular sieves. CONSTITUTION:Human urine is kept under alkaline condition and then treated with molecular sieves to afford the aimed factor. Furthermore, human urine collected from a patient suffering from a plastic anemia is preferably used as the human urine and pH is preferably kept at >=7.5. Membranes or gels of molecular sieves having about 50,000-200,000 cut molecular weight or gels (e.g. dextran or polyacrylamide derivative) are preferably used as the molecular sieves.
JP62209946A1987-08-241987-08-24Production of blood platelet growth factor
PendingJPS6452792A
(en)
PROCEDURE FOR TREATMENT OF CELLS WITH SOLUBLE BONE PROTEINS TO MAKE THEM SUITABLE FOR STIMULating THE GROWTH OF CARTILAGINE AND BONE TISSUES, AND THE PRODUCT OBTAINED
Angiotropins of leukocytes and inflamed tissue: a new class of natural chemotropic protein mitogens for specific induction of directional growth of blood vessels, neovascularization of tissues and morphogenesis of blood vessel patterns, process for their biotechnical preparation and pharmaceutical compositions
Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation